![]() |
|
![]() | ||
|
Subject:
ALX-0646
Category: Health > Medicine Asked by: badabing-ga List Price: $2.00 |
Posted:
24 Apr 2003 12:24 PDT
Expires: 24 May 2003 12:24 PDT Question ID: 194930 |
hello kids! do we have a proposed name for this new migraine med yet and is it a suma- or naratriptan? http://www.npsp.com/drug_development/dd_alx0646.php sorry, this question is worth way more than $2 but granny hopes someone will take pity upon her budget. thanks a virtual million! granny |
![]() | ||
|
There is no answer at this time. |
![]() | ||
|
Subject:
Re: ALX-0646
From: pinkfreud-ga on 24 Apr 2003 12:55 PDT |
Hi, Granny! This site describes ALX-0646 as a "Novel type of triptan serotonin (5HT1) antagonist." I would take "novel" to mean that it differs from almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan, and whatevertriptan. http://www.abpi.org.uk/publications/publication_details/targetMigraine/section6.asp Here's a description of the drug as "another triptan": http://216.239.33.100/search?q=cache:glPNtf3Aa3IC:www.neuroinv.com/NPScom.html Another use of the term "novel": "ALX-0646 is a novel compound that appears to be less likely to cause cardiovascular side effects than other migraine treatments currently on the market. It acts selectively on certain serotonin receptor subtypes in the brain and has low affinity for serotonin receptors in cardiovascular tissue." http://www.biospace.com/news_story.cfm?StoryID=6827415&full=1 Sorry, but I have not been able to find any announcement of a trade name. Hope someone else can get that for you. Thinking about this stuff sure can give a person a whopper ol' headache. ;-) ~Pink |
Subject:
Re: ALX-0646
From: justaskscott-ga on 24 Apr 2003 13:25 PDT |
It apparently didn't have a name as of National Headache Awareness Week 2002: "Pending Medications for Headache Treatment" National Headache Foundation http://www.headaches.org/consumer/presskit/NHAW02/NHAW02pendingmeds.html |
Subject:
Re: ALX-0646
From: badabing-ga on 24 Apr 2003 13:41 PDT |
yep, thought it would've made it outta trials by now. if you two master searchers can't find it, I doubt it's to be found. granny so appreciates your look time!! |
Subject:
Re: ALX-0646
From: tehuti-ga on 24 Apr 2003 14:00 PDT |
It is just out of phase I "A Phase I study showed that the compound was safe and well tolerated in human volunteers." http://www.npsp.com/drug_development/dd_alx0646.php Pafalafa's ABPI reference mentions these trials were conducted in the UK. Product pipeline: http://www.npsp.com/drug_development/pipeline.php No report of the phase I study in Medline and no journal entries turned up on Scirus.com. |
If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you. |
Search Google Answers for |
Google Home - Answers FAQ - Terms of Service - Privacy Policy |